Objectives: To examine the effect of 25-hydroxyvitamin D (25(OH)D) levels recommended by Endocrine Society guidelines (>30 ng/mL) on cognition in healthy older African-American women over 3 years.
Design: Randomized, double-blind, placebo-controlled clinical trial.
Setting: Bone Mineral Research Center at New York University Winthrop Hospital.